Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells

• Chen Peng,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America

  http://orcid.org/0000-0001-6141-8775

  ⨯
• Linda S. Wyatt,

  Roles Investigation, Writing – review & editing

  Affiliation Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America

  ⨯
• Shira G. Glushakow-Smith,

  Roles Investigation

  Affiliation Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America

  http://orcid.org/0000-0002-6012-7236

  ⨯
• Madhu Lal-Nag,

  Roles Methodology, Resources, Supervision, Writing – review & editing

  Affiliation Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States of America

  ⨯
• Andrea S. Weisberg,

  Roles Investigation, Writing – review & editing

  Affiliation Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America

  http://orcid.org/0000-0002-0330-5454

  ⨯
• Bernard Moss

  Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft

  * E-mail: bmoss@nih.gov

  Affiliation Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America

  http://orcid.org/0000-0002-2154-8564

  ⨯